In the last 12 months, insiders at C4 Therapeutics, Inc. ($CCCC) filed 180 transactions with the SEC: 0 open-market purchases totaling $0 and 3 sales totaling $25,851. Net insider sentiment: net selling.
C4 Therapeutics, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Hirsch Andrew (President & CEO) — 18 transactions totaling $268,287
- GROGAN DONNA ROY (Director) — 12 transactions totaling $140,499
- REYNO LEONARD (Chief Medical Officer) — 13 transactions totaling $130,231
- Anderson Kenneth Carl (Director) — 12 transactions totaling $113,499
- Adams Kendra (Chief Financial Officer) — 23 transactions totaling $93,339
View all SEC Filings for C4 Therapeutics, Inc. (CCCC).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Anderson Kenneth Carl | Director | A | Common Stock | 4259 | $2.70 | 354,515.0000 | 96,914,418 | 1.22% | 0.00% |
| April 1, 2026 | GROGAN DONNA ROY | Director | A | Common Stock | 5370 | $2.70 | 71,512.0000 | 96,914,418 | 8.12% | 0.01% |
| Feb. 15, 2026 | Hirsch Andrew | President & CEO | M | Common Stock | 20400 | $0.00 | 1,083,991.0000 | 96,914,418 | 1.92% | 0.02% |
| Feb. 14, 2026 | Hirsch Andrew | President & CEO | F | Common Stock | 39154 | $1.89 | 1,083,991.0000 | 96,914,418 | 3.49% | 0.04% |
| Feb. 14, 2026 | Hirsch Andrew | President & CEO | M | Common Stock | 81725 | $0.00 | 1,123,145.0000 | 96,914,418 | 7.85% | 0.08% |
| Feb. 13, 2026 | Hirsch Andrew | President & CEO | A | Common Stock | 700000 | $0.00 | 1,123,145.0000 | 96,914,418 | 165.43% | 0.72% |
| Feb. 14, 2026 | Schick Kelly | Chief People Officer | F | Common Stock | 7269 | $1.89 | 299,881.0000 | 96,914,418 | 2.37% | 0.01% |
| Feb. 14, 2026 | Schick Kelly | Chief People Officer | M | Common Stock | 20950 | $0.00 | 307,150.0000 | 96,914,418 | 7.32% | 0.02% |
| Feb. 13, 2026 | Schick Kelly | Chief People Officer | F | Common Stock | 1735 | $1.89 | 307,150.0000 | 96,914,418 | 0.56% | 0.00% |
| Feb. 13, 2026 | Schick Kelly | Chief People Officer | M | Common Stock | 5000 | $0.00 | 308,885.0000 | 96,914,418 | 1.65% | 0.01% |
| Feb. 13, 2026 | Schick Kelly | Chief People Officer | A | Common Stock | 200000 | $0.00 | 308,885.0000 | 96,914,418 | 183.68% | 0.21% |
| Feb. 14, 2026 | Mahaney Paige | Chief Scientific Officer | F | Common Stock | 2446 | $1.89 | 336,910.0000 | 96,914,418 | 0.72% | 0.00% |
| Feb. 13, 2026 | REYNO LEONARD | Chief Medical Officer | A | Common Stock | 240000 | $0.00 | 396,382.0000 | 96,914,418 | 153.47% | 0.25% |
| Feb. 13, 2026 | Mahaney Paige | Chief Scientific Officer | A | Common Stock | 240000 | $0.00 | 339,356.0000 | 96,914,418 | 241.56% | 0.25% |
| Feb. 14, 2026 | Boyle Scott N | Chief Business Officer | F | Common Stock | 7269 | $1.89 | 298,801.0000 | 96,914,418 | 2.37% | 0.01% |
| Feb. 14, 2026 | Boyle Scott N | Chief Business Officer | M | Common Stock | 20950 | $0.00 | 306,070.0000 | 96,914,418 | 7.35% | 0.02% |
| Feb. 13, 2026 | Boyle Scott N | Chief Business Officer | F | Common Stock | 1735 | $1.89 | 306,070.0000 | 96,914,418 | 0.56% | 0.00% |
| Feb. 13, 2026 | Boyle Scott N | Chief Business Officer | M | Common Stock | 5000 | $0.00 | 307,805.0000 | 96,914,418 | 1.65% | 0.01% |
| Feb. 13, 2026 | Boyle Scott N | Chief Business Officer | A | Common Stock | 200000 | $0.00 | 307,805.0000 | 96,914,418 | 185.52% | 0.21% |
| Feb. 14, 2026 | Mahaney Paige | Chief Scientific Officer | M | Common Stock | 7050 | $0.00 | 339,356.0000 | 96,914,418 | 2.12% | 0.01% |
| Feb. 15, 2026 | Hirsch Andrew | President & CEO | F | Common Stock | 9057 | $1.89 | 1,074,934.0000 | 96,914,418 | 0.84% | 0.01% |
| Feb. 14, 2026 | Mossler Mark | Chief Accounting Officer | F | Common Stock | 3268 | $1.89 | 71,916.0000 | 96,914,418 | 4.35% | 0.00% |
| Feb. 14, 2026 | Mossler Mark | Chief Accounting Officer | M | Common Stock | 9420 | $0.00 | 75,184.0000 | 96,914,418 | 14.32% | 0.01% |
| Feb. 13, 2026 | Mossler Mark | Chief Accounting Officer | A | Common Stock | 56980 | $0.00 | 75,184.0000 | 96,914,418 | 313.01% | 0.06% |
| Feb. 14, 2026 | Adams Kendra | Chief Financial Officer | F | Common Stock | 15381 | $1.89 | 385,098.0000 | 96,914,418 | 3.84% | 0.02% |
| Feb. 14, 2026 | Adams Kendra | Chief Financial Officer | M | Common Stock | 30950 | $0.00 | 400,479.0000 | 96,914,418 | 8.38% | 0.03% |
| Feb. 13, 2026 | Adams Kendra | Chief Financial Officer | F | Common Stock | 1863 | $1.89 | 400,479.0000 | 96,914,418 | 0.46% | 0.00% |
| Feb. 13, 2026 | Adams Kendra | Chief Financial Officer | M | Common Stock | 3750 | $0.00 | 402,342.0000 | 96,914,418 | 0.94% | 0.00% |
| Feb. 13, 2026 | Adams Kendra | Chief Financial Officer | A | Common Stock | 240000 | $0.00 | 402,342.0000 | 96,914,418 | 147.84% | 0.25% |
| Feb. 14, 2026 | REYNO LEONARD | Chief Medical Officer | F | Common Stock | 16579 | $1.89 | 379,803.0000 | 96,914,418 | 4.18% | 0.02% |
| Feb. 14, 2026 | REYNO LEONARD | Chief Medical Officer | M | Common Stock | 30950 | $0.00 | 396,382.0000 | 96,914,418 | 8.47% | 0.03% |
| Jan. 16, 2026 | REYNO LEONARD | Chief Medical Officer | S | Common Stock | 10000 | $2.22 | 156,382.0000 | 96,914,418 | 6.01% | 0.01% |
| Jan. 2, 2026 | Anderson Kenneth Carl | Director | A | Common Stock | 5958 | $1.93 | 350,256.0000 | 96,914,418 | 1.73% | 0.01% |
| Jan. 2, 2026 | GROGAN DONNA ROY | Director | A | Common Stock | 7513 | $1.93 | 66,142.0000 | 96,914,418 | 12.81% | 0.01% |
| Oct. 28, 2025 | Mahaney Paige | Chief Scientific Officer | F | Common Stock | 5644 | $2.58 | 99,356.0000 | 70,989,661 | 5.38% | 0.01% |
| Oct. 28, 2025 | Mahaney Paige | Chief Scientific Officer | M | Common Stock | 19200 | $0.00 | 105,000.0000 | 70,989,661 | 22.38% | 0.03% |
| Oct. 1, 2025 | GROGAN DONNA ROY | Director | A | Common Stock | 6740 | $2.15 | 58,629.0000 | 70,989,661 | 12.99% | 0.01% |
| Oct. 1, 2025 | Anderson Kenneth Carl | Director | A | Common Stock | 5349 | $2.15 | 344,298.0000 | 70,989,661 | 1.58% | 0.01% |
| Sept. 18, 2025 | Adams Kendra | Chief Financial Officer | M | Common Stock | 6250 | $0.00 | 165,117.0000 | 70,989,661 | 3.93% | 0.01% |
| Sept. 18, 2025 | Adams Kendra | Chief Financial Officer | F | Common Stock | 2775 | $3.32 | 162,342.0000 | 70,989,661 | 1.68% | 0.00% |
| July 10, 2025 | REYNO LEONARD | Chief Medical Officer | M | Common Stock | 15325 | $0.00 | 173,764.0000 | 70,989,661 | 9.67% | 0.02% |
| July 10, 2025 | REYNO LEONARD | Chief Medical Officer | F | Common Stock | 7382 | $1.99 | 166,382.0000 | 70,989,661 | 4.25% | 0.01% |
| July 10, 2025 | REYNO LEONARD | Chief Medical Officer | F | Common Stock | 7382 | $1.99 | 166,382.0000 | 70,989,661 | 4.25% | 0.01% |
| July 1, 2025 | GROGAN DONNA ROY | Director | A | Common Stock | 9609 | $1.51 | 51,889.0000 | 70,989,661 | 22.73% | 0.01% |
| July 1, 2025 | Anderson Kenneth Carl | Director | A | Common Stock | 7616 | $1.51 | 338,949.0000 | 70,989,661 | 2.30% | 0.01% |
| June 18, 2025 | GROGAN DONNA ROY | Director | A | Stock Option (Right to Buy) | 35500 | $0.00 | 35,500.0000 | 70,989,661 | 9999.99% | 0.05% |
| June 18, 2025 | Hoerter Steven L. | Director | A | Stock Option (Right to Buy) | 35500 | $0.00 | 35,500.0000 | 70,989,661 | 9999.99% | 0.05% |
| June 18, 2025 | Koppikar Utpal | Director | A | Stock Option (Right to Buy) | 35500 | $0.00 | 35,500.0000 | 70,989,661 | 9999.99% | 0.05% |
| June 18, 2025 | Hughes Owen | Director | A | Stock Option (Right to Buy) | 35500 | $0.00 | 35,500.0000 | 70,989,661 | 9999.99% | 0.05% |
| June 18, 2025 | Fawell Stephen | Director | A | Stock Option (Right to Buy) | 35500 | $0.00 | 35,500.0000 | 70,989,661 | 9999.99% | 0.05% |
| June 18, 2025 | Bessen Laura | Director | A | Stock Option (Right to Buy) | 35500 | $0.00 | 35,500.0000 | 70,989,661 | 9999.99% | 0.05% |
| June 18, 2025 | Cooper Ronald Harold Wilfred | Director | A | Stock Option (Right to Buy) | 35500 | $0.00 | 35,500.0000 | 70,989,661 | 9999.99% | 0.05% |
| June 18, 2025 | Anderson Kenneth Carl | Director | A | Stock Option (Right to Buy) | 35500 | $0.00 | 35,500.0000 | 70,989,661 | 9999.99% | 0.05% |
| April 1, 2025 | Anderson Kenneth Carl | Director | A | Common Stock | 7841 | $1.44 | 331,333.0000 | 70,989,661 | 2.42% | 0.01% |
| April 1, 2025 | GROGAN DONNA ROY | Director | A | Common Stock | 9581 | $1.44 | 42,280.0000 | 70,989,661 | 29.30% | 0.01% |
| Feb. 14, 2025 | Boyle Scott N | Chief Business Officer | S | Common Stock | 490 | $3.15 | 110,842.0000 | 0 | 0.44% | 0.00% |
| Feb. 14, 2025 | Hirsch Andrew | President & CEO | A | Common Stock | 223500 | $0.00 | 445,362.0000 | 0 | 100.74% | 0.00% |
| Feb. 14, 2025 | Hirsch Andrew | President & CEO | F | Common Stock | 12847 | $3.18 | 432,515.0000 | 0 | 2.88% | 0.00% |
| Feb. 15, 2025 | Hirsch Andrew | President & CEO | F | Common Stock | 9370 | $3.18 | 423,145.0000 | 0 | 2.17% | 0.00% |
| Feb. 14, 2025 | Hirsch Andrew | President & CEO | A | Stock Option (Right to Buy) | 335300 | $0.00 | 335,300.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Siegel Jolie | Chief Legal Officer | F | Common Stock | 2135 | $3.20 | 54,353.0000 | 0 | 3.78% | 0.00% |
| Feb. 14, 2025 | Siegel Jolie | Chief Legal Officer | A | Common Stock | 56500 | $0.00 | 110,853.0000 | 0 | 103.95% | 0.00% |
| Feb. 14, 2025 | Siegel Jolie | Chief Legal Officer | F | Common Stock | 2914 | $3.18 | 107,939.0000 | 0 | 2.63% | 0.00% |
| Feb. 14, 2025 | Siegel Jolie | Chief Legal Officer | A | Stock Option (Right to Buy) | 84700 | $0.00 | 84,700.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Boyle Scott N | Chief Business Officer | F | Common Stock | 1735 | $3.20 | 54,832.0000 | 0 | 3.07% | 0.00% |
| Feb. 14, 2025 | Boyle Scott N | Chief Business Officer | A | Common Stock | 56500 | $0.00 | 111,332.0000 | 0 | 103.04% | 0.00% |
| Feb. 14, 2025 | Boyle Scott N | Chief Business Officer | F | Common Stock | 2368 | $3.18 | 108,474.0000 | 0 | 2.14% | 0.00% |
| Feb. 18, 2025 | Boyle Scott N | Chief Business Officer | S | Common Stock | 669 | $3.15 | 107,805.0000 | 0 | 0.62% | 0.00% |
| Feb. 14, 2025 | Boyle Scott N | Chief Business Officer | A | Stock Option (Right to Buy) | 84700 | $0.00 | 84,700.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2025 | Mossler Mark | Chief Accounting Officer | F | Common Stock | 1586 | $3.18 | 18,204.0000 | 0 | 8.01% | 0.00% |
| Feb. 13, 2025 | Schick Kelly | Chief People Officer | F | Common Stock | 1735 | $3.20 | 54,753.0000 | 0 | 3.07% | 0.00% |
| Feb. 14, 2025 | Schick Kelly | Chief People Officer | A | Common Stock | 56500 | $0.00 | 111,253.0000 | 0 | 103.19% | 0.00% |
| Feb. 14, 2025 | Schick Kelly | Chief People Officer | F | Common Stock | 2368 | $3.18 | 108,885.0000 | 0 | 2.13% | 0.00% |
| Feb. 14, 2025 | Schick Kelly | Chief People Officer | A | Stock Option (Right to Buy) | 84700 | $0.00 | 84,700.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Adams Kendra | Chief Financial Officer | F | Common Stock | 1863 | $3.20 | 82,576.0000 | 0 | 2.21% | 0.00% |
| Feb. 14, 2025 | Adams Kendra | Chief Financial Officer | A | Common Stock | 87100 | $0.00 | 169,676.0000 | 0 | 105.48% | 0.00% |
| Feb. 14, 2025 | Adams Kendra | Chief Financial Officer | F | Common Stock | 4559 | $3.18 | 165,117.0000 | 0 | 2.69% | 0.00% |
| Feb. 14, 2025 | Adams Kendra | Chief Financial Officer | A | Stock Option (Right to Buy) | 130600 | $0.00 | 130,600.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2025 | Mahaney Paige | Chief Scientific Officer | A | Common Stock | 28200 | $0.00 | 105,000.0000 | 0 | 36.72% | 0.00% |
| Feb. 14, 2025 | Mahaney Paige | Chief Scientific Officer | A | Stock Option (Right to Buy) | 42400 | $0.00 | 42,400.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2025 | REYNO LEONARD | Chief Medical Officer | A | Common Stock | 87100 | $0.00 | 178,909.0000 | 0 | 94.87% | 0.00% |
| Feb. 14, 2025 | REYNO LEONARD | Chief Medical Officer | F | Common Stock | 5145 | $3.18 | 173,764.0000 | 0 | 2.88% | 0.00% |
| Feb. 14, 2025 | REYNO LEONARD | Chief Medical Officer | A | Stock Option (Right to Buy) | 130600 | $0.00 | 130,600.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Anderson Kenneth Carl | Director | A | Common Stock | 3074 | $3.66 | 323,492.0000 | 0 | 0.96% | 0.00% |
| Jan. 2, 2025 | GROGAN DONNA ROY | Director | A | Common Stock | 3757 | $3.66 | 32,699.0000 | 0 | 12.98% | 0.00% |
| Nov. 19, 2024 | Hoerter Steven L. | Director | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2024 | Adams Kendra | Chief Financial Officer | F | Common Stock | 1102 | $6.04 | 84,439.0000 | 0 | 1.29% | 0.00% |
| Nov. 7, 2024 | Schick Kelly | Chief People Officer | M | Common Stock | 3750 | $0.00 | 57,590.0000 | 0 | 6.97% | 0.00% |
| Nov. 7, 2024 | Schick Kelly | Chief People Officer | F | Common Stock | 1102 | $6.04 | 56,488.0000 | 0 | 1.91% | 0.00% |
| Nov. 7, 2024 | Boyle Scott N | Chief Business Officer | M | Common Stock | 3750 | $0.00 | 57,669.0000 | 0 | 6.95% | 0.00% |
| Nov. 7, 2024 | Boyle Scott N | Chief Business Officer | F | Common Stock | 1102 | $6.04 | 56,567.0000 | 0 | 1.91% | 0.00% |
| Nov. 7, 2024 | Boyle Scott N | Chief Business Officer | M | Performance Restricted Stock Units | 3750 | $0.00 | 10,500.0000 | 0 | 26.32% | 0.00% |
| Nov. 7, 2024 | Adams Kendra | Chief Financial Officer | M | Common Stock | 3750 | $0.00 | 85,541.0000 | 0 | 4.58% | 0.00% |
| Nov. 7, 2024 | Adams Kendra | Chief Financial Officer | M | Performance Restricted Stock Units | 3750 | $0.00 | 10,500.0000 | 0 | 26.32% | 0.00% |
| Nov. 7, 2024 | Hirsch Andrew | President & CEO | M | Performance Restricted Stock Units | 12500 | $0.00 | 35,000.0000 | 0 | 26.32% | 0.00% |
| Nov. 7, 2024 | Hirsch Andrew | President & CEO | F | Common Stock | 5550 | $6.04 | 221,862.0000 | 0 | 2.44% | 0.00% |
| Nov. 7, 2024 | Hirsch Andrew | President & CEO | M | Common Stock | 12500 | $0.00 | 227,412.0000 | 0 | 5.82% | 0.00% |
| Nov. 7, 2024 | Siegel Jolie | Chief Legal Officer | M | Performance Restricted Stock Units | 3750 | $0.00 | 10,500.0000 | 0 | 26.32% | 0.00% |
| Nov. 7, 2024 | Siegel Jolie | Chief Legal Officer | F | Common Stock | 1102 | $6.04 | 56,488.0000 | 0 | 1.91% | 0.00% |
| Nov. 7, 2024 | Siegel Jolie | Chief Legal Officer | M | Common Stock | 3750 | $0.00 | 57,590.0000 | 0 | 6.97% | 0.00% |
| Nov. 7, 2024 | Schick Kelly | Chief People Officer | M | Performance Restricted Stock Units | 3750 | $0.00 | 10,500.0000 | 0 | 26.32% | 0.00% |
| Oct. 28, 2024 | Mahaney Paige | Chief Scientific Officer | A | Stock Option (Right to Buy) | 345600 | $0.00 | 345,600.0000 | 0 | 9999.99% | 0.00% |
| Oct. 28, 2024 | Mahaney Paige | Chief Scientific Officer | A | Common Stock | 76800 | $0.00 | 76,800.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2024 | GROGAN DONNA ROY | Director | A | Common Stock | 2474 | $5.56 | 28,942.0000 | 0 | 9.35% | 0.00% |
| Oct. 1, 2024 | Anderson Kenneth Carl | Director | A | Common Stock | 2023 | $5.56 | 320,418.0000 | 0 | 0.64% | 0.00% |
| Sept. 18, 2024 | Adams Kendra | Chief Financial Officer | F | Common Stock | 1837 | $6.38 | 81,791.0000 | 0 | 2.20% | 0.00% |
| Sept. 16, 2024 | Boyle Scott N | Chief Business Officer | F | Common Stock | 661 | $6.36 | 53,919.0000 | 0 | 1.21% | 0.00% |
| Sept. 16, 2024 | Siegel Jolie | Chief Legal Officer | M | Performance Restricted Stock Units | 2250 | $0.00 | 14,250.0000 | 0 | 13.64% | 0.00% |
| Sept. 16, 2024 | Siegel Jolie | Chief Legal Officer | F | Common Stock | 661 | $6.36 | 53,840.0000 | 0 | 1.21% | 0.00% |
| Sept. 16, 2024 | Hirsch Andrew | President & CEO | F | Common Stock | 3329 | $6.36 | 214,912.0000 | 0 | 1.53% | 0.00% |
| Sept. 16, 2024 | Hirsch Andrew | President & CEO | M | Performance Restricted Stock Units | 7500 | $0.00 | 47,500.0000 | 0 | 13.64% | 0.00% |
| Sept. 16, 2024 | Boyle Scott N | Chief Business Officer | M | Common Stock | 2250 | $0.00 | 54,580.0000 | 0 | 4.30% | 0.00% |
| Sept. 16, 2024 | Boyle Scott N | Chief Business Officer | M | Performance Restricted Stock Units | 2250 | $0.00 | 14,250.0000 | 0 | 13.64% | 0.00% |
| Sept. 16, 2024 | Adams Kendra | Chief Financial Officer | M | Common Stock | 2250 | $0.00 | 84,289.0000 | 0 | 2.74% | 0.00% |
| Sept. 16, 2024 | Adams Kendra | Chief Financial Officer | F | Common Stock | 661 | $6.36 | 83,628.0000 | 0 | 0.78% | 0.00% |
| Sept. 16, 2024 | Adams Kendra | Chief Financial Officer | M | Performance Restricted Stock Units | 2250 | $0.00 | 14,250.0000 | 0 | 13.64% | 0.00% |
| Sept. 16, 2024 | Fisher Stewart | Chief Scientific Officer | M | Common Stock | 2250 | $0.00 | 131,371.0000 | 0 | 1.74% | 0.00% |
| Sept. 16, 2024 | Fisher Stewart | Chief Scientific Officer | F | Common Stock | 661 | $6.36 | 130,710.0000 | 0 | 0.50% | 0.00% |
| Sept. 16, 2024 | Fisher Stewart | Chief Scientific Officer | M | Performance Restricted Stock Units | 2250 | $0.00 | 14,250.0000 | 0 | 13.64% | 0.00% |
| Sept. 16, 2024 | Schick Kelly | Chief People Officer | M | Common Stock | 2250 | $0.00 | 54,501.0000 | 0 | 4.31% | 0.00% |
| Sept. 16, 2024 | Schick Kelly | Chief People Officer | F | Common Stock | 661 | $6.36 | 53,840.0000 | 0 | 1.21% | 0.00% |
| Sept. 16, 2024 | Schick Kelly | Chief People Officer | M | Performance Restricted Stock Units | 2250 | $0.00 | 14,250.0000 | 0 | 13.64% | 0.00% |
| Sept. 16, 2024 | Siegel Jolie | Chief Legal Officer | M | Common Stock | 2250 | $0.00 | 54,501.0000 | 0 | 4.31% | 0.00% |
| Sept. 16, 2024 | Hirsch Andrew | President & CEO | M | Common Stock | 7500 | $0.00 | 218,241.0000 | 0 | 3.56% | 0.00% |
| Aug. 29, 2024 | Fawell Stephen | Director | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| July 10, 2024 | REYNO LEONARD | Chief Medical Officer | F | Common Stock | 6191 | $5.00 | 91,809.0000 | 0 | 6.32% | 0.00% |
| July 1, 2024 | Anderson Kenneth Carl | Director | A | Common Stock | 2320 | $4.85 | 318,395.0000 | 0 | 0.73% | 0.00% |
| July 1, 2024 | GROGAN DONNA ROY | Director | A | Common Stock | 2836 | $4.85 | 26,468.0000 | 0 | 12.00% | 0.00% |
| June 20, 2024 | Anderson Kenneth Carl | Director | A | Stock Option (Right to Buy) | 32500 | $0.00 | 32,500.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | DOWNEY BRUCE | Director | A | Stock Option (Right to Buy) | 32500 | $0.00 | 32,500.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Koppikar Utpal | Director | A | Stock Option (Right to Buy) | 32500 | $0.00 | 32,500.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Bessen Laura | Director | A | Stock Option (Right to Buy) | 32500 | $0.00 | 32,500.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | GROGAN DONNA ROY | Director | A | Stock Option (Right to Buy) | 32500 | $0.00 | 32,500.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Hughes Owen | Director | A | Stock Option (Right to Buy) | 32500 | $0.00 | 32,500.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Salter Malcolm | Director | A | Stock Option (Right to Buy) | 32500 | $0.00 | 32,500.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2024 | Cooper Ronald Harold Wilfred | Director | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Mossler Mark | Chief Accounting Officer | A | Common Stock | 18290 | $0.00 | 19,790.0000 | 0 | 1219.33% | 0.00% |
| Feb. 14, 2024 | Mossler Mark | Chief Accounting Officer | A | Stock Option (Right to Buy) | 27430 | $0.00 | 27,430.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2024 | Anderson Kenneth Carl | Director | A | Common Stock | 1389 | $8.10 | 316,075.0000 | 0 | 0.44% | 0.00% |
| April 1, 2024 | Dubin Glenn | Director | A | Common Stock | 1358 | $8.10 | 812,682.0000 | 0 | 0.17% | 0.00% |
| April 1, 2024 | GROGAN DONNA ROY | Director | A | Common Stock | 1697 | $8.10 | 23,632.0000 | 0 | 7.74% | 0.00% |
| March 7, 2024 | Boyle Scott N | Chief Business Officer | D | Stock Option (Right to Buy) | 115000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 7, 2024 | Boyle Scott N | Chief Business Officer | A | Stock Option (Right to Buy) | 115000 | $0.00 | 115,000.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2024 | Fisher Stewart | Chief Scientific Officer | D | Stock Option (Right to Buy) | 94950 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 7, 2024 | Siegel Jolie | Chief Legal Officer | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2024 | Siegel Jolie | Chief Legal Officer | D | Stock Option (Right to Buy) | 90000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 7, 2024 | Siegel Jolie | Chief Legal Officer | A | Stock Option (Right to Buy) | 84850 | $0.00 | 84,850.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2024 | Siegel Jolie | Chief Legal Officer | D | Stock Option (Right to Buy) | 84850 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 7, 2024 | Adams Kendra | Chief Financial Officer | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2024 | Adams Kendra | Chief Financial Officer | D | Stock Option (Right to Buy) | 45000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 7, 2024 | Schick Kelly | Chief People Officer | A | Stock Option (Right to Buy) | 78500 | $0.00 | 78,500.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2024 | Schick Kelly | Chief People Officer | D | Stock Option (Right to Buy) | 78500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 7, 2024 | Schick Kelly | Chief People Officer | A | Stock Option (Right to Buy) | 92000 | $0.00 | 92,000.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2024 | Schick Kelly | Chief People Officer | D | Stock Option (Right to Buy) | 92000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 7, 2024 | Fisher Stewart | Chief Scientific Officer | A | Stock Option (Right to Buy) | 118000 | $0.00 | 118,000.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2024 | Fisher Stewart | Chief Scientific Officer | D | Stock Option (Right to Buy) | 118000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 7, 2024 | Fisher Stewart | Chief Scientific Officer | A | Stock Option (Right to Buy) | 94950 | $0.00 | 94,950.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | REYNO LEONARD | Chief Medical Officer | A | Stock Option (Right to Buy) | 165300 | $0.00 | 165,300.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Hirsch Andrew | President & CEO | A | Stock Option (Right to Buy) | 465500 | $0.00 | 465,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Hirsch Andrew | President & CEO | A | Common Stock | 103400 | $0.00 | 217,301.0000 | 0 | 90.78% | 0.00% |
| Feb. 15, 2024 | Hirsch Andrew | President & CEO | F | Common Stock | 6560 | $7.90 | 210,741.0000 | 0 | 3.02% | 0.00% |
| Feb. 14, 2024 | REYNO LEONARD | Chief Medical Officer | A | Common Stock | 36700 | $0.00 | 98,000.0000 | 0 | 59.87% | 0.00% |
| Feb. 14, 2024 | Adams Kendra | Chief Financial Officer | A | Stock Option (Right to Buy) | 165300 | $0.00 | 165,300.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Adams Kendra | Chief Financial Officer | A | Common Stock | 36700 | $0.00 | 82,039.0000 | 0 | 80.95% | 0.00% |
| Feb. 13, 2024 | Adams Kendra | Chief Financial Officer | F | Common Stock | 1301 | $6.53 | 45,339.0000 | 0 | 2.79% | 0.00% |
| Feb. 14, 2024 | Boyle Scott N | Chief Business Officer | A | Stock Option (Right to Buy) | 122800 | $0.00 | 122,800.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Boyle Scott N | Chief Business Officer | A | Common Stock | 27300 | $0.00 | 52,330.0000 | 0 | 109.07% | 0.00% |
| Feb. 13, 2024 | Boyle Scott N | Chief Business Officer | F | Common Stock | 1735 | $6.53 | 25,030.0000 | 0 | 6.48% | 0.00% |
| Feb. 14, 2024 | Fisher Stewart | Chief Scientific Officer | A | Stock Option (Right to Buy) | 122800 | $0.00 | 122,800.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Fisher Stewart | Chief Scientific Officer | A | Common Stock | 27300 | $0.00 | 129,121.0000 | 0 | 26.81% | 0.00% |
| Feb. 13, 2024 | Fisher Stewart | Chief Scientific Officer | F | Common Stock | 2255 | $6.53 | 101,821.0000 | 0 | 2.17% | 0.00% |
| Feb. 14, 2024 | Schick Kelly | Chief People Officer | A | Stock Option (Right to Buy) | 122800 | $0.00 | 122,800.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Schick Kelly | Chief People Officer | A | Common Stock | 27300 | $0.00 | 52,251.0000 | 0 | 109.41% | 0.00% |
| Feb. 13, 2024 | Schick Kelly | Chief People Officer | F | Common Stock | 1735 | $6.53 | 24,951.0000 | 0 | 6.50% | 0.00% |
| Feb. 14, 2024 | Siegel Jolie | Chief Legal Officer | A | Stock Option (Right to Buy) | 122800 | $0.00 | 122,800.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Siegel Jolie | Chief Legal Officer | A | Common Stock | 27300 | $0.00 | 52,251.0000 | 0 | 109.41% | 0.00% |
| Feb. 13, 2024 | Siegel Jolie | Chief Legal Officer | F | Common Stock | 1735 | $6.53 | 24,951.0000 | 0 | 6.50% | 0.00% |
| Jan. 2, 2024 | GROGAN DONNA ROY | Director | A | Common Stock | 2108 | $6.52 | 21,935.0000 | 0 | 10.63% | 0.00% |
| Jan. 2, 2024 | Dubin Glenn | Director | A | Common Stock | 1687 | $6.52 | 811,324.0000 | 0 | 0.21% | 0.00% |
| Jan. 2, 2024 | Anderson Kenneth Carl | Director | A | Common Stock | 1725 | $6.52 | 314,686.0000 | 0 | 0.55% | 0.00% |